| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 8.527 | 11.855 | 608 | 5.366 | 5.069 | 5.960 | 4.754 | 2.140 | 668 | 766 |
| Total Income - EUR | 8.631 | 11.892 | 608 | 5.584 | 5.689 | 5.960 | 4.939 | 2.528 | 668 | 766 |
| Total Expenses - EUR | 11.397 | 13.094 | 3.927 | 11.491 | 13.173 | 3.028 | 10.574 | 3.830 | 1.870 | 2.103 |
| Gross Profit/Loss - EUR | -2.766 | -1.202 | -3.319 | -5.907 | -7.484 | 2.932 | -5.634 | -1.302 | -1.202 | -1.337 |
| Net Profit/Loss - EUR | -3.025 | -1.443 | -3.337 | -5.963 | -7.531 | 2.784 | -5.634 | -1.364 | -1.234 | -1.360 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 |
Check the financial reports for the company - Diageno Com Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.586 | 5.737 | 5.484 | 5.231 | 4.980 | 4.885 | 4.639 | 4.516 | 4.365 | 4.203 |
| Current Assets | 6.193 | 3.177 | 3.304 | 1.587 | 7.965 | 5.255 | 3.353 | 5.041 | 4.768 | 6.544 |
| Inventories | 6.005 | 3.009 | 3.061 | 1.085 | 7.588 | 5.072 | 3.332 | 4.848 | 4.791 | 6.801 |
| Receivables | 154 | 153 | 169 | 147 | 145 | 147 | 17 | 0 | 0 | 89 |
| Cash | 33 | 15 | 74 | 355 | 232 | 36 | 4 | 194 | -23 | -346 |
| Shareholders Funds | -2.686 | -1.107 | -3.293 | -5.920 | -13.336 | 2.826 | -2.871 | -1.323 | -2.553 | -3.899 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 11.464 | 10.022 | 12.081 | 12.737 | 26.280 | 7.314 | 10.863 | 10.880 | 11.686 | 14.646 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5630 - 5630" | |||||||||
| CAEN Financial Year |
5630
|
|||||||||
Comments - Diageno Com Srl